⌘K

Home/Insiders/Lorrain Daniel S.

LD

SEC Insider//CIK 0001861550

Lorrain Daniel S.

CIK 00018615501 companySAN DIEGO, CA

Transactions

9

Companies

1

Filings

5

CIK

0001861550

Recent Transactions

9 trades

Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-01-05$11.13/sh−500→ 160,222 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-01-05$10.35/sh−3,670→ 160,722 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2025-01-31+3,700→ 3,700 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2025-01-31+110,000→ 110,000 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2024-11-25$16.02/sh−1,010→ 168,562 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2024-11-18$17.05/sh−99→ 169,572 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2024-11-18$16.37/sh−6,091→ 169,671 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2024-05-24+100,000→ 100,000 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2024-05-24+3,700→ 3,700 total

Companies

1

Contineum Therapeutics, Inc.
Chief Scientific Officer
$CTNM

Recent Filings

5

Address

3565 GENERAL ATOMICS COURT, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov